Organigram Global Inc. announced the launch of SHRED Shotz, a 65‑ml cannabis beverage that uses the company’s proprietary FAST (Fast Acting Soluble Technology) nanoemulsion platform to deliver a 15‑minute onset.
The SHRED brand surpassed $200 million in retail sales in Fiscal Year 2025, a milestone that underscores the brand’s strong market presence and provides a solid foundation for the new product launch.
Industry analysts project the cannabis‑derived beverage market to reach between $2.96 billion and $19.06 billion globally by 2028, with U.S. sales expected to hit $2.8 billion in the same period, reflecting continued legalization and consumer demand for convenient, fast‑acting options.
By combining the SHRED brand’s equity with FAST technology, Organigram aims to capture a larger share of the ready‑to‑consume segment and generate incremental revenue, reinforcing its strategy of focusing on high‑margin, ready‑to‑consume categories.
Organigram’s recent financial performance—record revenues, improved EBITDA, and strategic acquisitions such as Motif Labs—provides the scale and capital needed to support the launch and accelerate market penetration.
Management highlighted the product as a key growth driver, noting that the FAST platform’s faster onset and improved bioavailability position Organigram ahead of competitors in a crowded market.
No immediate market reaction data is available for this announcement.
The content on EveryTicker is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.